基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02616 基石药业-B

未开盘 12-12 16:08:09

6.120

+0.370

+6.43%

最高6.160	最低5.760	成交量1,004万
今开5.810	昨收5.750	日振幅6.96%
总市值90.33亿	流通市值90.33亿	总股本14.76亿
成交额6,050万	换手率0.68%	流通股本14.76亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02616","market":"HK","secType":"STK","nameCN":"基石药业-B","latestPrice":6.12,"timestamp":1765526889007,"preClose":5.75,"halted":0,"volume":10039898,"delay":0,"floatShares":1476000000,"shares":1476000000,"eps":-0.07885125572940994,"marketStatus":"未开盘","change":0.37,"latestTime":"12-12 16:08:09","open":5.81,"high":6.16,"low":5.76,"amount":60504298,"amplitude":0.069565,"askPrice":6.12,"askSize":8500,"bidPrice":6.07,"bidSize":12500,"shortable":3,"etf":0,"ttmEps":-0.3219731106414448,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":0,"adr":0,"listingDate":1551110400000,"exchange":"SEHK","adjPreClose":5.75,"openAndCloseTimeList":[[1765503000000,1765512000000],[1765515600000,1765526400000]],"volumeRatio":0.994570126882226,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02616/tweets","defaultTab":"tweets","newsList":[{"id":"2590529262","title":"港股异动 | 基石药业-B(02616)涨超5% 普拉替尼获纳入国家医保目录 公司2.0管线矩阵持续扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2590529262","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590529262?lang=zh_cn&edition=full","pubTime":"2025-12-12 10:55","pubTimestamp":1765508156,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，基石药业-B涨超5%，截至发稿，涨5.57%，报6.07港元，成交额2270.42万港元。消息面上，基石药业近日宣布，公司RET抑制剂普吉华被成功纳入中国国家医疗保障局公布的最新版《国家基本医疗保险、生育保险和工伤保险药品目录》，该目录将于2026年1月1日起正式实施。截至目前，基石药业已成功推进4款创新药获批上市，其中3款由基石药业在中国完成临床试验及注册获批上市的产品，已被纳入国家医保目录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2590233595","title":"【券商聚焦】交银国际：创新药增量支付空间持续扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2590233595","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590233595?lang=zh_cn&edition=full","pubTime":"2025-12-12 09:02","pubTimestamp":1765501348,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓整体平稳，内外资加大创新药布局的大方向不变。该机构指，本周医保+商保双目录落地，医保谈判新增品种成功率创近年新高，续约品种降价幅度相对温和。该机构认为商保资金的引入将为创新药支付带来重要增量资金，进一步优化多元支付体系。该机构看好医保新纳入品种/适应症在2026年的销售放量，以及首版商保目录的实际执行和支付情况。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971425","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002463.SGD","159992","LU1951186391.HKD","LU0043850808.USD","LU2778985437.USD","HK0000165453.HKD","LU0181495838.USD","LU0516423091.SGD","LU0067412154.USD","LU2097828557.USD","LU0502904849.HKD","LU1226287529.USD","LU0359201612.USD","LU0634319403.HKD","LU1961090484.USD","01801","02142","LU0708995583.HKD","02616","LU0417516738.SGD","BK1161","01877","LU0359202008.SGD","09995","02269","LU1993786604.SGD","LU1969619763.USD","SG9999004220.SGD","01093","LU0540923850.HKD","LU0880133367.SGD","LU2039709279.SGD","BK1588","LU1770034418.SGD","06160","LU0348766576.USD","01177","06185","LU2097828714.EUR","03329","09688","LU2097828631.EUR","LU0456827905.SGD","LU2242644610.SGD","09926","LU2328871848.SGD","IE00B0JY6N72.USD","LU1794554557.SGD","06978","LU1242518931.SGD"],"gpt_icon":0},{"id":"2590562491","title":"每日卖空追踪 | 基石药业-B 12月10日卖空量成交191.75万股，卖空比例为10.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590562491","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590562491?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355432,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间12月10日，涨6.25%，卖空量成交191.75万股，较上一交易日减少7.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016350495353d6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016350495353d6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"2590624505","title":"基石药业-B12月10日主力净流入29.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590624505","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590624505?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:15","pubTimestamp":1765354551,"startTime":"0","endTime":"0","summary":"12月10日, 基石药业-B股价涨6.25%，报收5.95元，成交金额1.1亿元，换手率1.29%，振幅8.21%，量比2.87。基石药业-B今日主力资金净流入29.5万元，上一交易日主力净流出84.9万元。该股近5个交易日上涨6.77%，主力资金累计净流入291.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出920.0万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210162102a72f4617&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210162102a72f4617&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02616","BK1161","BK1574"],"gpt_icon":0},{"id":"2590320442","title":"基石药业-B(02616.HK)获非执行董事胡正国增持100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590320442","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590320442?lang=zh_cn&edition=full","pubTime":"2025-12-10 07:37","pubTimestamp":1765323421,"startTime":"0","endTime":"0","summary":"格隆汇12月10日丨根据联交所最新权益披露资料显示，2025年12月4日，基石药业-B(02616.HK)获非执行董事胡正国在场内以每股均价5.7546港元增持100万股，涉资约575.46万港元。\r\n\r\n　　增持后，胡正国最新持股数目为347.1万股，持股比例由0.17%上升至0.24%。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/10/20251210241614.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/10/20251210241614.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251210/31854557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"2590393976","title":"港股基石药业-B早盘一度涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590393976","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590393976?lang=zh_cn&edition=full","pubTime":"2025-12-09 10:08","pubTimestamp":1765246136,"startTime":"0","endTime":"0","summary":"每经AI快讯，基石药业-B(02616.HK)早盘一度涨超3%，截至发稿，涨2.51%，报5.71港元，成交额729.04万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512093586235060.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512093586235060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"2590367035","title":"【券商聚焦】交银国际：2025年医保+商保双目录落地 多元支付体系盘活创新药增量空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2590367035","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590367035?lang=zh_cn&edition=full","pubTime":"2025-12-09 08:59","pubTimestamp":1765241994,"startTime":"0","endTime":"0","summary":"调整后的目录中，药品总数增至3,253种。新版目录将于2026年1月1日正式实施。该机构认为，更多新药进入目录有助于提升临床用药水平，及创新药行业整体研发回报率；商保资金的引入将为创新药支付带来重要增量资金，为多元化支付体系的建立奠定基础。百济有两款产品纳入商保创新药目录，信达、和黄各有一款纳入。同时重点关注首批商保目录的实际执行和支付情况、名单及定价的动态调整以及真实世界数据积累带来的长期发展机会。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971149","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU1813983027.USD","IE00BZ08YR35.GBP","09926","06185","LU1719994722.HKD","09995","BK1576","LU0417516902.SGD","LU2039709279.SGD","01801","LU0348766576.USD","BK1574","LU1951186391.HKD","LU0456827905.SGD","LU0880133367.SGD","LU0326950275.SGD","LU1969619763.USD","01177","LU0572944931.SGD","LU0516423091.SGD","01093","LU1226288170.HKD","01877","BK1147","BK1610","BK1588","02616","BK1161","02269","LU2399975544.HKD","06978","LU0348784397.USD","159992","BK1141","LU0140636845.USD","LU0708995583.HKD","LU1720050803.USD","09688","IE00B543WZ88.USD","LU0327786744.USD","03329","IE00B0JY6N72.USD","06160","LU0348767384.USD","LU0348783233.USD","LU2476274308.USD","02142","LU0181495838.USD","LU1770034418.SGD"],"gpt_icon":0},{"id":"2589332612","title":"非执行董事胡正国增持基石药业(02616)100万股 每股作价约5.75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589332612","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589332612?lang=zh_cn&edition=full","pubTime":"2025-12-08 19:06","pubTimestamp":1765191997,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，12月4日，非执行董事胡正国增持基石药业(02616)100万股，每股作价5.7546港元，总金额为575.46万港元。增持后最新持股数目为347.1万股，持股比例为0.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2589868243","title":"基石药业-B(02616)：普吉华®(普拉替尼胶囊)获纳入2025年国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589868243","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589868243?lang=zh_cn&edition=full","pubTime":"2025-12-08 12:21","pubTimestamp":1765167715,"startTime":"0","endTime":"0","summary":"智通财经APP讯，基石药业-B 发布公告，公司普吉华已被纳入中国国家医疗保障局公布的最新版《国家基本医疗保险、生育保险和工伤保险药品目录》，该目录将于2026年1月1日起正式实施。普吉华是一种口服、每日一次的靶向治疗药物。普吉华由基石药业合作伙伴Blueprint Medicines公司开发。2023年11月，基石药业将普吉华在中国大陆区域的独家商业化推广权授予上海艾力斯医药科技股份有限公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"基石药业-B(02616)：普吉华®(普拉替尼胶囊)获纳入2025年国家医保目录","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"1171138252","title":"基石药业（02616）发布2025年11月月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1171138252","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171138252?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:59","pubTimestamp":1764838777,"startTime":"0","endTime":"0","summary":"基石药业于2025年12月4日公布截至2025年11月30日的股份变动月报。报告显示，公司法定注册股本维持2,000,000,000股，面值0.0001美元，注册股本总额200,000美元，与上月无异动。已发行股本方面，截至2025年11月底，公司已发行股份数为1,475,977,923股，较上月保持不变。首次公开发售后员工持股计划中，有7,500份期权于本月内失效，对公司已发行股份总数无实质影响。公司表示，将继续遵守香港联合交易所有限公司上市规则及相关法律。公告由董事李伟签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"gpt_icon":0},{"id":"2588887931","title":"每日卖空追踪 | 基石药业-B 12月04日卖空量成交68.5万股，卖空比例为11.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588887931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588887931?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837033,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间12月04日，涨2.85%，卖空量成交68.5万股，较上一交易日减少64.2%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163505a4cc380b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163505a4cc380b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"2588166730","title":"基石药业-B12月03日主力净流出248.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588166730","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588166730?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749747,"startTime":"0","endTime":"0","summary":"12月03日, 基石药业-B股价跌1.92%，报收5.61元，成交金额3087.1万元，换手率0.37%，振幅4.72%，量比0.59。基石药业-B今日主力资金净流出248.5万元，上一交易日主力净流入158.9万元。该股近5个交易日下跌5.05%，主力资金累计净流出232.2万元；近20日主力资金累计净流出3435.9万元，其中净流出天数为10日。该股主力净额占比0.03%，港股市场排名2510/2682。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203161954a4c9e5f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203161954a4c9e5f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2588974776","title":"每日卖空追踪 | 基石药业-B 12月01日卖空量成交37万股，卖空比例为4.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588974776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588974776?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577832,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间12月01日，跌6.22%，卖空量成交37万股，较上一交易日减少70.82%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163446a4c551ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163446a4c551ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02616"],"gpt_icon":0},{"id":"2588177699","title":"基石药业-B12月01日主力净流出429.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588177699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588177699?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576933,"startTime":"0","endTime":"0","summary":"12月01日, 基石药业-B股价跌6.22%，报收5.73元，成交金额5190.9万元，换手率0.61%，振幅9.17%，量比1.05。基石药业-B今日主力资金净流出429.6万元，上一交易日主力净流入9.1万元。该股近5个交易日上涨1.96%，主力资金累计净流出1157.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出3413.8万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116173397894b75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116173397894b75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2586970219","title":"港股异动 | 基石药业-B(02616)现涨超5% 欧盟委员会批准舒格利单抗用于治疗III期非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2586970219","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586970219?lang=zh_cn&edition=full","pubTime":"2025-11-27 13:43","pubTimestamp":1764222201,"startTime":"0","endTime":"0","summary":"消息面上，基石药业宣布，欧盟委员会已批准舒格利单抗的新适应症：单药治疗肿瘤细胞PD-L1表达≥1%、无EGFR敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期非小细胞肺癌成人患者。基石药业将继续推进舒格利单抗在全球的可及性，践行对患者的长期承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","02616","III","BK1161","BK1574"],"gpt_icon":0},{"id":"2586250477","title":"舒格利单抗再传捷报！Ⅲ期非小细胞肺癌适应症在欧洲正式获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250477","media":"药学进展","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586250477?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:01","pubTimestamp":1764147691,"startTime":"0","endTime":"0","summary":"中国苏州，2025年11月25日——基石药业，一家专注于肿瘤、自身免疫与炎症等关键疾病领域药物研发的创新驱动型生物医药企业，今日宣布欧盟委员会已批准舒格利单抗的新适应症：单药用于治疗肿瘤细胞PD-L1表达≥1%、无表皮生长因子受体敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的Ⅲ期非小细胞肺癌成人患者。截至目前，公司已成功上市4款创新药、获批16项新药上市申请以及9项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126194136a712e6a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126194136a712e6a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2586504702","title":"每日卖空追踪 | 基石药业-B 11月26日卖空量成交113.25万股，卖空比例为9.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586504702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586504702?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:30","pubTimestamp":1764145828,"startTime":"0","endTime":"0","summary":"基石药业-B北京时间11月26日，涨5.32%，卖空量成交113.25万股，较上一交易日增加61.55%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163446951b4bc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163446951b4bc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02616","BK1161"],"gpt_icon":0},{"id":"2586289799","title":"港股基石药业-B涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586289799","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586289799?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:17","pubTimestamp":1764123476,"startTime":"0","endTime":"0","summary":"每经AI快讯，基石药业-B(02616.HK)涨超5%，截至发稿，涨5.32%，报5.94港元，成交额822.94万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511263575192480.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511263575192480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2586095286","title":"港股异动 | 基石药业-B(02616)涨超5% 欧盟委员会已批准舒格利单抗的新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2586095286","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586095286?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:58","pubTimestamp":1764122332,"startTime":"0","endTime":"0","summary":"消息面上，11月25日，基石药业公布，欧盟委员会已批准舒格利单抗的新适应症：单药治疗肿瘤细胞PD-L1 表达≥1%、无EGFR敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期非小细胞肺癌成人患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 基石药业-B(02616)涨超5% 欧盟委员会已批准舒格利单抗的新适应症","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","02616"],"gpt_icon":0},{"id":"2586445523","title":"基石药业-B(02616)：舒格利单抗获欧盟委员会批准用于治疗Ⅲ期非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2586445523","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586445523?lang=zh_cn&edition=full","pubTime":"2025-11-25 12:10","pubTimestamp":1764043854,"startTime":"0","endTime":"0","summary":"智通财经APP讯，基石药业-B 公布，欧盟委员会已批准舒格利单抗的新适应症：单药治疗肿瘤细胞PD-L1 表达≥1%、无EGFR敏感突变或ALK、ROS1基因组变异、在含铂放化疗后未出现疾病进展的、不可切除的III期非小细胞肺癌成人患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"基石药业-B(02616)：舒格利单抗获欧盟委员会批准用于治疗Ⅲ期非小细胞肺癌","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","02616"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cstonepharma.com","stockEarnings":[{"period":"1week","weight":0.0794},{"period":"1month","weight":0.1087},{"period":"3month","weight":-0.388},{"period":"6month","weight":0.3362},{"period":"1year","weight":1.3359},{"period":"ytd","weight":1.6609}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"基石药业是一家主要专注于抗肿瘤药物研发的生物制药投资控股公司。该公司通过子公司主要从事生物制药产品的研发、销售药品及提供其知识产权授权或商业化授权。该公司主要产品包括精准治疗药物泰吉华（阿伐替尼）及普吉华（普拉替尼）。该公司还从事肿瘤免疫药物的开发及商业化。该公司主要在中国国内和海外市场开展业务，如中欧及东欧和瑞士。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.062298},{"month":2,"riseRate":0.333333,"avgChangeRate":0.039956},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.10478},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.048094},{"month":5,"riseRate":0.5,"avgChangeRate":0.100514},{"month":6,"riseRate":0.714286,"avgChangeRate":0.09443},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05639},{"month":8,"riseRate":0.428571,"avgChangeRate":0.079119},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.071005},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.012196},{"month":11,"riseRate":0.571429,"avgChangeRate":0.010396},{"month":12,"riseRate":0.571429,"avgChangeRate":0.024398}],"exchange":"SEHK","name":"基石药业-B","nameEN":"CSTONE PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基石药业-B,02616,基石药业-B股票,基石药业-B股票老虎,基石药业-B股票老虎国际,基石药业-B行情,基石药业-B股票行情,基石药业-B股价,基石药业-B股市,基石药业-B股票价格,基石药业-B股票交易,基石药业-B股票购买,基石药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基石药业-B(02616)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基石药业-B(02616)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}